This PDF file includes: (left) and spliced XBP1 (right) was performed by quantitative RT-PCR as detailed in the Materials and Methods. HEK293 cells were transfected with Arf1-Q71L plasmids (48 h) or treated with thapsigargin (5 μM, 12 h). Some cells were pretreated with XBP1-specific siRNA for 48 h. The results of multiple experiments are summarized (n = 3). Thapsigargin, but not Arf1-Q71L, increased both total and spliced XBP1 mRNA levels. (C) Effects of IRE1α-and XBP1-specific siRNAs on XBP1 splicing. HEK293 cells were treated with thapsigargin (5 μM, 12 h) and/or transfected with the indicated siRNAs (100 nM, 48 h). Thapsigargin increased the protein level of spliced XBP1 (XBP1s), which was reduced by siRNAs against IRE1α or XBP1. (48 h) and identified with phospho-specific antibodies. Representative immunoblots are shown in A and the results of multiple experiments are summarized in B (n = 3). The IC 50 values of APY29 on IRE1α and ASK1 phosphorylation were 9.6 and 6.2 μM, respectively. (C-F) Protein stability of WT-and ΔF508-CFTR was analyzed in HEK293 cells treated with the protein synthesis inhibitor cycloheximide. Cells were transfected with plasmids encoding for WT-or ΔF508-CFTR (48 h). Some cells were co-transfected with Arf1-Q71L plasmids to induce UPS. Surface biotinylation assays were performed after incubation with cycloheximide (0.1 mg/mL) for the indicated time periods. Representative results of WT-CFTR and ΔF508-CFTR are shown in C and D, respectively. Quantification of the CFTR levels at the cell-surface and total lysates in control and Arf1-Q71L-transfected cells are summarized in E and F, respectively (each n = 3). Protein stability of ΔF508-CFTR is lower than WT-CFTR under all conditions. Data are shown as the mean ± SEM. **P < 0.01, compared to WT-CFTR. Comparison of the ΔF508-CFTR rescue effects induced by VX-809 and CSTMP. Surface biotinylation assays were performed in HEK293 cells treated with the CFTR corrector VX-809 (10 μM) and CSTMP (10 μM) for 24 h. Representative surface biotinylation results are shown in E, and the results of multiple experiments (n = 3) are summarized in F. VX-809 evoked the cell-surface expression of ΔF508-CFTR band C protein, which was not inhibited by APY29. **P < 0.01, n.s., not significant. b, core-glycosylated CFTR. c, complex-glycosylated CFTR. Bar graph data are shown as the mean ± SEM.
Fig. S5. CSTMP induces the cell surface expression of ΔF508-CFTR via UPS. (A and B)
The Nglycosylation status of CFTR was analyzed. Both the total cell lysates and biotinylated fractions were digested with N-glycosidase F (PNGase F), which removes all N-linked carbohydrates, or with Endoglycosidase H (Endo H), which removes the ER-mediated N-linked carbohydrates. The cellsurface expressed band B (b) forms of WT-and ΔF508-CFTRs were Endo H-sensitive Three independent experiments showed similar results. (C and D) Dominant-inhibitory mutants of Sar1-GTPase (Sar1-T39N and Sar1-H79G), which inhibit conventional COPII-mediated ER-to-Golgi trafficking, were co-transfected and surface biotinylation assays were performed. Representative surface biotinylation results are presented in C and the results of multiple experiments (n = 3) are summarized in D. Sar1 mutants did not block the CSTMP-induced, cell-surface expression of band B forms of WT-and ΔF508-CFTRs. (E and F) Syntaxin 5 was overexpressed to induce Golgi acceptor blockade and surface biotinylation assays were performed. Representative surface biotinylation results are presented in E and the results of multiple experiments (n = 3) are summarized in F. Syntaxin 5 overexpression did not block the CSTMP-induced, cell-surface expression of band B forms of WT-and ΔF508-CFTRs. Data are shown as the mean ± SEM. a, deglycosylated CFTR, b, core-glycosylated CFTR. c, complex-glycosylated CFTR. **P < 0.01, n.s., not significant. (A, B) The Nglycosylation status of pendrin was analyzed. PANC-1 cells were transfected with plasmids encoding WT-or p.H723R-pendrin and further incubated with CSTMP (30 μM) for 48 h. Both the total cell lysates and biotinylated fractions were digested with N-glycosidase F (PNGase F) and Endoglycosidase H (Endo H). The cell-surface expressed band B (b) form of p.H723R-pendrin was Endo H-sensitive, while the band C (c) form of WT-pendrin was Endo H-resistant. Three independent experiments showed similar results. (C-F) Surface biotinylation assays were performed in PANC-1 cells with co-transfecting plasmids expressing Sar1-T39N, which inhibit COPII-mediated ER-to-Golgi transport. Representative surface biotinylation assay results are presented in C (WTpendrin) and E (p.H723R-pendrin). Results of multiple experiments (each n = 34) are summarized in D (WT-pendrin) and F (p.H723R-pendrin). Sar1-T39N did not block the CSTMP-induced, cellsurface rescue of p.H723R-pendrin, but it blocked the cell surface expression of band C form of WTpendrin. The ER-to-Golgi blockade by Sar1-T39N also evoked UPS of WT-and p.H723R-pendrins. a, deglycosylated pendrin, b, core-glycosylated pendrin. c, complex-glycosylated pendrin. Data are shown as the mean ± SEM. **P < 0.01, n.s., not significant. (saline) or CSTMP at a dose of 2.59 mg/kg (equivalent to 10 μM, assuming CSTMP is evenly distributed throughout the body), 25.9 mg/kg (equivalent to 100 μM), or 259 mg/kg (equivalent to 1,000 μM) once daily for 5 days. The survival curves were plotted. The LD 50 value was estimated to be 25.9 mg/kg/day. No mice died on the 2.59 mg/kg/day dosing schedule.
